Leading
the way

Testing developed
by neurologists, for neurologists

Neurology testing is rapidly evolving, with increasing numbers of clinically relevant biomarkers discovered each year. Our laboratory collaborates closely with the practice and is designed to offer the most complex, clinically validated testing. Our disease experts support health care professionals in test selection and results interpretation to ensure proper test utilization and the highest quality of care. These physicians are committed to research and discovery to pave the way for the future of neurology testing. 

Stay up-to-date on the latest discoveries and test launches. Sign up for our monthly neurology newsletter.

Results that matter

We're dedicated to our patients' health and well-being,
and proud of the outstanding outcomes we achieve.


400+

laboratory tests developed for our specialized neurology test menu


169

neurologists on staff at Mayo Clinic


19

testing laboratories performing
neurology testing


24/7

support from Mayo Clinic physicians and scientists




Advancing the
science

Novel biomarker discoveries occur at a rapid pace, and we are at the forefront of research that integrates these findings into our testing. We were the first laboratory to develop disease-specific evaluations, and our patient care experience gives us the expertise to develop tests that deliver clinically relevant answers.

The largest neurology-specific test menu

Our highly specialized test menu provides answers for everything from the simplest to the most complex cases — and much of this testing is not available anywhere else. 

Access to Mayo Clinic expertise

Our laboratories are led by clinical neurologists who have extensive experience in using testing to guide and directly impact patient care. These experts interpret each evaluation, providing clinically actionable answers, not just results. 


Advancing the search for KLHL11 protein biomarkers

The groundbreaking discovery that testicular cancer-associated paraneoplastic encephalitis is caused by KLHL11 autoantibodies — by a team of researchers that included Mayo Clinic scientists — paved the way for development of the assay. The innovative test first screens patients for KLHL11 proteins through a mechanized, cell-based assay that utilizes cutting-edge, slide-scanner technology, then employs tissue immunofluorescence to confirm presence of the protein, which exudes a unique "sparkles" pattern.

The latest

By MCL Education • July 22, 2021
By MCL Education • July 5, 2021
By Samantha Rossi • June 22, 2021
By Suzanne Ferguson • June 16, 2021
By MCL Education • May 24, 2021